Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166016 · ClinicalTrials.gov registry record · NA
Treatment Effects on Gait in Hammertoe Patients
A NA study of Hammertoe, sponsored by University of Texas Rio Grande Valley.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07166016: Recruiting NA study of Hammertoe, sponsored by University of Texas Rio Grande Valley.
NCT07166016 is a NA study of Hammertoe that is actively recruiting participants, run by University of Texas Rio Grande Valley. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166016, a NA study of Hammertoe, is actively recruiting participants, sponsored by University of Texas Rio Grande Valley.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at how hammertoe deformities affect foot pressure distribution and whether proper treatment can improve quality of life.
Primary Outcome
In-shoe peak plantar pressure data will be recorded as patients walk with a pressure-measuring sensor placed inside their shoes. The unit will be Kilopascal (kPa).
Conditions Studied
Interventions
- OTHER Conservative
- PROCEDURE Surgical
Study Locations (1)
Texas
- University of Texas Rio Grande Valley - Harlingen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07166016 shows while recruiting
NCT07166016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hammertoe appearing as the primary indexed condition, and to 2 interventions - of which Conservative is the first listed.
NCT07166016 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07166016 about?
NCT07166016 is a clinical study titled "Treatment Effects on Gait in Hammertoe Patients". This study looks at how hammertoe deformities affect foot pressure distribution and whether proper treatment can improve quality of life.
What is the current status of trial NCT07166016?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07166016 study?
This clinical trial studies the following conditions: Hammertoe.
What interventions are being tested in trial NCT07166016?
The interventions under investigation include: Conservative (OTHER), Surgical (PROCEDURE).
Who is sponsoring clinical trial NCT07166016?
This trial is sponsored by University of Texas Rio Grande Valley, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07166016 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07166016's enrollment target sits among peer trials
30 1594th of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI